U.S. markets closed

Twist Bioscience Corporation (TWST)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
116.62-13.38 (-10.29%)
At close: 4:00PM EST

116.60 -0.02 (-0.02%)
After hours: 7:37PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Performance Outlook
Previous Close130.00
Open125.38
Bid112.00 x 900
Ask124.00 x 1000
Day's Range113.76 - 131.91
52 Week Range18.52 - 214.07
Volume1,540,980
Avg. Volume890,461
Market Cap5.673B
Beta (5Y Monthly)0.76
PE Ratio (TTM)N/A
EPS (TTM)-2.76
Earnings DateFeb 04, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est153.75
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Twist Bioscience and Watchmaker Genomics Announce Partnership to Drive New Applications of High-throughput Genetic Sequencing
    Business Wire

    Twist Bioscience and Watchmaker Genomics Announce Partnership to Drive New Applications of High-throughput Genetic Sequencing

    Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Watchmaker Genomics today announced a broad partnership to enable innovative research across a wide range of high throughput sequencing applications including oncology and tumor profiling, inherited disease detection, liquid biopsy assays, and minimal residual disease monitoring.

  • Twist Bioscience to Highlight Genotyping by Sequencing and Methylation Solution During AGBT
    Business Wire

    Twist Bioscience to Highlight Genotyping by Sequencing and Methylation Solution During AGBT

    Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced several events at the virtual 2021 Advances in Genome Biology and Technology (AGBT) meeting to be held March 1-3, 2021.

  • Benzinga

    Twist Bioscience Launches Methylation Detection Systems

    Twist Bioscience Corp (NASDAQ: TWST) has launched its NGS Methylation Detection System, end-to-end sample preparation, and target enrichment solution for identifying methylated regions in the human genome. DNA methylation plays a key role in many biological processes, including cancer. A methyl group can alter genetic behavior without changing the DNA sequence when present on a single nucleotide. In cancer methylation, patterns appear early, providing an approach for screening through liquid biopsy tests designed to detect a wide range of tumors from a single blood sample. Also, Twist has partnered with New England Biolabs (NEB), which have developed an enzyme-based alternative to sodium bisulfite treatment, EM-seqTM, for the preparation of samples for methylation analysis. Earlier this week, Twist Bioscience and China's Berry Genomics announced a partnership on next-generation sequencing target enrichment and library preparation tools. Price Action: TWST is up 2.02% at $138.02 in market trading hours on the last check Wednesday. See more from BenzingaClick here for options trades from BenzingaTwist Bioscience Collaborates With Australia Based Specialist Provider For Whole Exome Capture Assay© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.